v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating activities:    
Net loss $ (11,902) $ (6,901)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 632 782
Changes in allowance for doubtful accounts (11) 48
Gain on forgiveness of note payable 0 (1,099)
Gain on revaluation of warrant liabilities (1,011) (2,011)
Stock-based compensation expense 1,618 1,538
Common stock contribution to 401(k) plan 147 141
Unrealized loss on foreign currency transactions 1,704 640
Changes in operating assets and liabilities:    
Accounts receivable 1,044 (10)
Inventories (1,477) (171)
Prepaid expenses and other assets, current and noncurrent (277) (251)
Accounts payable (704) (189)
Accrued, lease and other liabilities, current and noncurrent (270) (70)
Deferred revenues (537) (528)
Net cash used in operating activities (11,044) (8,081)
Investing activities:    
Acquisition of property and equipment (141) (60)
Net cash used in investing activities (141) (60)
Financing activities:    
Proceeds from issuance of common stock and warrants, net 0 37,295
Proceeds from exercise of warrants 0 1,417
Net cash provided by financing activities 0 38,712
Effect of exchange rate changes on cash (41) 6
Net (decrease) increase in cash (11,226) 30,577
Cash at beginning of period 40,406 12,862
Cash at end of period 29,180 43,439
Supplemental disclosure of cash flow activities    
Cash paid for interest 88 69
Cash paid for income taxes 14 0
Supplemental disclosure of non-cash activities    
Fair value of warrants issued upon equity financing 0 1,936
Reclassification of warrant liability to equity upon exercise of warrants 0 2,461
Transfer of inventory to property and equipment 192 387
Initial recognition of operating lease liabilities and right of use assets 1,459 0
Share issuance for common stock contribution to 401(k) plan $ 176 $ 152

Source